News & Notes > NIH iSearch COVID-19 Portfolio Includes medRxiv and bioRxiv Preprints

NIH iSearch COVID-19 Portfolio Includes medRxiv and bioRxiv Preprints

bioRxiv | 2020-04-17

Preprints from bioRxiv and medRxiv are included in the iSearch COVID-19 portfolio created by the NIH Office of Portfolio Analysis. The portfolio is a daily-updated, expert-curated comprehensive collection of publications and preprints related to the SARS CoV 2 pandemic. It includes peer-reviewed articles from PubMed and preprints from medRxiv, bioRxiv, ChemRxiv, and arXiv, permitting users to explore and analyze advances in COVID-19 research as they accumulate in real time.

Recent Posts

Request a review using B2C

Broadening audience, increasing understanding

bioRxiv & medRxiv launch additional social media accounts

bioRxiv expands on Mastodon and Bluesky

Preprint withdrawals

bioRxiv and PaperPlayer partner to pilot a new feature - Audio Abstracts - allowing readers to listen to audio versions of neuroscience abstracts

bioRxiv and medRxiv thank the following for their generous financial support:

The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.